Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Small Molecule Libraries | 5 | 2021 | 746 | 1.610 |
Why?
|
| Zinc | 3 | 2022 | 677 | 1.130 |
Why?
|
| Proline | 5 | 2016 | 456 | 0.960 |
Why?
|
| Proteins | 8 | 2023 | 6008 | 0.830 |
Why?
|
| Esters | 2 | 2013 | 212 | 0.760 |
Why?
|
| Silicon | 1 | 2022 | 143 | 0.760 |
Why?
|
| Insulin-Secreting Cells | 6 | 2023 | 900 | 0.730 |
Why?
|
| Models, Chemical | 3 | 2016 | 611 | 0.730 |
Why?
|
| Optical Phenomena | 1 | 2020 | 106 | 0.690 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 430 | 0.690 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2024 | 1905 | 0.680 |
Why?
|
| Electrons | 5 | 2014 | 266 | 0.670 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2023 | 42 | 0.660 |
Why?
|
| Thalidomide | 2 | 2024 | 885 | 0.650 |
Why?
|
| Ubiquitin | 1 | 2023 | 843 | 0.610 |
Why?
|
| Synthetic Biology | 1 | 2020 | 187 | 0.600 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 341 | 0.600 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 687 | 0.570 |
Why?
|
| Bacteriophages | 1 | 2020 | 382 | 0.540 |
Why?
|
| Alkenes | 2 | 2016 | 54 | 0.520 |
Why?
|
| Stereoisomerism | 5 | 2014 | 612 | 0.500 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 1969 | 0.500 |
Why?
|
| Peptides | 5 | 2016 | 4368 | 0.440 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 940 | 0.430 |
Why?
|
| Genetic Engineering | 1 | 2019 | 936 | 0.420 |
Why?
|
| Molecular Structure | 6 | 2021 | 1889 | 0.420 |
Why?
|
| Chromogenic Compounds | 1 | 2011 | 30 | 0.400 |
Why?
|
| Molecular Conformation | 6 | 2014 | 542 | 0.400 |
Why?
|
| Thioamides | 1 | 2011 | 1 | 0.390 |
Why?
|
| Carbohydrate Biochemistry | 1 | 2011 | 1 | 0.390 |
Why?
|
| Amides | 3 | 2012 | 452 | 0.370 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1725 | 0.370 |
Why?
|
| B-Lymphocytes | 2 | 2022 | 4781 | 0.350 |
Why?
|
| Quantum Theory | 1 | 2010 | 69 | 0.340 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 452 | 0.330 |
Why?
|
| Models, Molecular | 10 | 2013 | 5443 | 0.330 |
Why?
|
| Crystallography, X-Ray | 7 | 2019 | 1987 | 0.320 |
Why?
|
| Luminescent Proteins | 1 | 2011 | 839 | 0.320 |
Why?
|
| Conserved Sequence | 1 | 2011 | 1164 | 0.310 |
Why?
|
| Oxides | 1 | 2010 | 403 | 0.300 |
Why?
|
| Nucleotides | 1 | 2010 | 455 | 0.290 |
Why?
|
| Nucleic Acids | 1 | 2010 | 190 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 3440 | 0.290 |
Why?
|
| Hydrogen Bonding | 3 | 2011 | 292 | 0.270 |
Why?
|
| Genomics | 1 | 2022 | 5909 | 0.270 |
Why?
|
| RNA | 2 | 2021 | 2727 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 12242 | 0.260 |
Why?
|
| Phosphorylation | 4 | 2022 | 8332 | 0.240 |
Why?
|
| Hydroxyproline | 2 | 2016 | 110 | 0.230 |
Why?
|
| Protein Conformation | 4 | 2015 | 3973 | 0.220 |
Why?
|
| Imidazolidines | 2 | 2013 | 38 | 0.210 |
Why?
|
| Directed Molecular Evolution | 1 | 2024 | 162 | 0.210 |
Why?
|
| Ionophores | 1 | 2022 | 108 | 0.200 |
Why?
|
| Zinc Fingers | 1 | 2024 | 577 | 0.190 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2023 | 394 | 0.190 |
Why?
|
| Ions | 1 | 2022 | 257 | 0.190 |
Why?
|
| Chelating Agents | 1 | 2022 | 385 | 0.180 |
Why?
|
| Glycosylation | 1 | 2023 | 1100 | 0.170 |
Why?
|
| Proteomics | 1 | 2014 | 3901 | 0.170 |
Why?
|
| Biology | 2 | 2023 | 291 | 0.170 |
Why?
|
| Islets of Langerhans | 2 | 2023 | 1349 | 0.170 |
Why?
|
| Static Electricity | 2 | 2011 | 261 | 0.170 |
Why?
|
| Thermodynamics | 5 | 2012 | 594 | 0.170 |
Why?
|
| Pyrrolidines | 2 | 2012 | 341 | 0.170 |
Why?
|
| Aspirin | 1 | 2011 | 3139 | 0.170 |
Why?
|
| Trimethoprim | 1 | 2019 | 80 | 0.160 |
Why?
|
| Molecular Probes | 1 | 2021 | 310 | 0.160 |
Why?
|
| Insulin Infusion Systems | 1 | 2020 | 221 | 0.160 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2019 | 133 | 0.160 |
Why?
|
| Prodrugs | 1 | 2020 | 274 | 0.150 |
Why?
|
| Catalysis | 1 | 2020 | 769 | 0.150 |
Why?
|
| Transcription Factors | 2 | 2023 | 12174 | 0.150 |
Why?
|
| Substrate Specificity | 2 | 2019 | 1775 | 0.150 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2019 | 199 | 0.150 |
Why?
|
| Metals | 1 | 2022 | 713 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2010 | 6278 | 0.140 |
Why?
|
| Protein Kinase C | 1 | 2022 | 1207 | 0.140 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 81 | 0.140 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 293 | 0.140 |
Why?
|
| Mammals | 1 | 2022 | 1136 | 0.130 |
Why?
|
| Endonucleases | 1 | 2019 | 371 | 0.130 |
Why?
|
| Genome, Viral | 1 | 2020 | 673 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 1339 | 0.130 |
Why?
|
| Isomerism | 2 | 2016 | 198 | 0.130 |
Why?
|
| INDEL Mutation | 1 | 2016 | 267 | 0.130 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 1563 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2019 | 549 | 0.120 |
Why?
|
| Cell Line | 3 | 2020 | 15609 | 0.120 |
Why?
|
| Immune System | 1 | 2020 | 801 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2014 | 30 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1095 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 151 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2021 | 825 | 0.110 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 1100 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 343 | 0.110 |
Why?
|
| Catalytic Domain | 2 | 2016 | 709 | 0.110 |
Why?
|
| Protein Structure, Secondary | 3 | 2011 | 1223 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2021 | 1062 | 0.110 |
Why?
|
| Halogens | 1 | 2012 | 13 | 0.110 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2012 | 21 | 0.110 |
Why?
|
| Ketones | 1 | 2014 | 182 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1751 | 0.100 |
Why?
|
| Light | 1 | 2019 | 1357 | 0.100 |
Why?
|
| Protein Stability | 2 | 2011 | 584 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2019 | 3790 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.100 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 561 | 0.100 |
Why?
|
| Physical Phenomena | 1 | 2011 | 48 | 0.100 |
Why?
|
| DNA | 2 | 2019 | 7213 | 0.090 |
Why?
|
| Evolution, Chemical | 1 | 2010 | 3 | 0.090 |
Why?
|
| Genome | 1 | 2019 | 1749 | 0.090 |
Why?
|
| Fluorides | 1 | 2011 | 134 | 0.090 |
Why?
|
| Molecular Mimicry | 1 | 2011 | 214 | 0.090 |
Why?
|
| Binding Sites | 1 | 2019 | 6030 | 0.090 |
Why?
|
| Hexanes | 1 | 2009 | 6 | 0.090 |
Why?
|
| Humans | 19 | 2024 | 768451 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 13452 | 0.080 |
Why?
|
| Azabicyclo Compounds | 1 | 2009 | 68 | 0.080 |
Why?
|
| RNA Precursors | 1 | 2010 | 197 | 0.080 |
Why?
|
| Fluorescence | 1 | 2011 | 760 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 6527 | 0.080 |
Why?
|
| Collagen | 2 | 2015 | 2646 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5808 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2232 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4294 | 0.070 |
Why?
|
| Protein Folding | 1 | 2011 | 875 | 0.070 |
Why?
|
| Animals | 7 | 2023 | 169418 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 899 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3169 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2072 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2024 | 1010 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2882 | 0.060 |
Why?
|
| Protein Binding | 2 | 2016 | 9376 | 0.060 |
Why?
|
| Fluoresceins | 1 | 2023 | 236 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2023 | 126 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 3783 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7599 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17149 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2023 | 432 | 0.050 |
Why?
|
| Glucagon | 1 | 2023 | 534 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 3111 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19041 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11930 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 652 | 0.040 |
Why?
|
| Insulin | 2 | 2023 | 6606 | 0.040 |
Why?
|
| Hydroxylation | 1 | 2016 | 139 | 0.030 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2016 | 35 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 2477 | 0.030 |
Why?
|
| Cell Communication | 1 | 2023 | 1662 | 0.030 |
Why?
|
| Mice | 3 | 2023 | 82045 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 3073 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9505 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2023 | 1818 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2023 | 2889 | 0.030 |
Why?
|
| Protein Carbonylation | 1 | 2012 | 28 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1669 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 1924 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 2422 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3463 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 467 | 0.020 |
Why?
|
| Glucose | 1 | 2023 | 4355 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5904 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 204 | 0.020 |
Why?
|
| Kinetics | 1 | 2016 | 6348 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 1050 | 0.020 |
Why?
|
| Dipeptides | 1 | 2010 | 386 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2023 | 23638 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 5801 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10494 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2834 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2204 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2014 | 6429 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9526 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 23839 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 3546 | 0.010 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_